Search stocks

Find any stock by ticker or company name

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Избранное
Рынки
Скринер
Новости
О нас

BWAY - BrainsWay Ltd. Последние новости | Finranks

Home

/

BWAY

B

BrainsWay Ltd. (BWAY)

NGM – Цена в реальном времени. Валюта: USD

14.48

-0.06 (-0.41%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

14.48

0.00 (0.00%)

После закрытия: Jun 26, 2026, 4:43 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting

BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting

Preliminary Data Analysis Reveals Over 80% Remission Rate One Year after Accelerated Deep TMS Treatment, with Decline in Severe Functional Impairment from 85% to 0% Preliminary Data Analysis Reveals Over 80% Remission Rate One Year after Accelerated Deep TMS Treatment, with Decline in Severe Functional Impairment from 85% to 0%

BrainsWay Announces Minority-Stake Investment in Hopemark Health

BrainsWay Announces Minority-Stake Investment in Hopemark Health

Investment in provider servicing clinics in Illinois is latest in series of similar transactions by BrainsWay with leading North American mental health providers to raise awareness and expand access to transformative care Investment in provider servicing clinics in Illinois is latest in series of similar transactions by BrainsWay with leading North American mental health providers to raise awareness and expand access to transformative care

BrainsWay Ltd. (BWAY) Q1 2026 Earnings Call Transcript

BrainsWay Ltd. (BWAY) Q1 2026 Earnings Call Transcript

BrainsWay Ltd. (BWAY) Q1 2026 Earnings Call Transcript

Brainsway Q1 Earnings Call Highlights

Brainsway Q1 Earnings Call Highlights

Brainsway NASDAQ: BWAY reported a strong start to 2026, with first-quarter revenue rising 35% year over year as the company expanded placements of its Deep TMS systems and continued to build its recurring revenue base.

BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights

BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights

R evenue grew approximately 35 % y ear- o ver- y ear to $1 5 .5 million for Q1 2026

Are Medical Stocks Lagging Brainsway (BWAY) This Year?

Are Medical Stocks Lagging Brainsway (BWAY) This Year?

Here is how Brainsway Ltd. Sponsored ADR (BWAY) and CG Oncology, Inc. (CGON) have performed compared to their sector so far this year.

Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why

Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why

Brainsway (BWAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Видео

No Data

There is no data to display

Пресс-релизы

BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting

BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting

Preliminary Data Analysis Reveals Over 80% Remission Rate One Year after Accelerated Deep TMS Treatment, with Decline in Severe Functional Impairment from 85% to 0% Preliminary Data Analysis Reveals Over 80% Remission Rate One Year after Accelerated Deep TMS Treatment, with Decline in Severe Functional Impairment from 85% to 0%

BrainsWay Announces Minority-Stake Investment in Hopemark Health

BrainsWay Announces Minority-Stake Investment in Hopemark Health

Investment in provider servicing clinics in Illinois is latest in series of similar transactions by BrainsWay with leading North American mental health providers to raise awareness and expand access to transformative care Investment in provider servicing clinics in Illinois is latest in series of similar transactions by BrainsWay with leading North American mental health providers to raise awareness and expand access to transformative care

BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights

BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights

R evenue grew approximately 35 % y ear- o ver- y ear to $1 5 .5 million for Q1 2026

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

Growing payer acceptance of nurse practitioner administration of Deep TMS is expected to expand access to non‑drug mental health treatments Growing payer acceptance of nurse practitioner administration of Deep TMS is expected to expand access to non‑drug mental health treatments